Look back in anger - what clinical studies tell us about preclinical work.
Look back in anger - what clinical studies tell us about preclinical work.
复制标题
DOI:
10.14573/altex.2013.3.275
复制
发表时间:
2013
期刊:
影响因子:
--
通讯作者:
Hartung T
中科院分区:
文献类型:
--
作者:
Hartung T
Misled by animal studies and basic research? Whenever we take a closer look at the outcome of clinical trials in a field such as, most recently, stroke or septic shock, we see how limited the value of our preclinical models was. For all indications, 95% of drugs that enter clinical trials do not make it to the market, despite all promise of the (animal) models used to develop them. Drug development has started already to decrease its reliance on animal models: In Europe, for example, despite increasing R&D expenditure, animal use by pharmaceutical companies dropped by more than 25% from 2005 to 2008. In vitro studies are likewise limited: questionable cell authenticity, over-passaging, mycoplasma infections, and lack of differentiation as well as non-homeostatic and non-physiologic culture conditions endanger the relevance of these models. The standards of statistics and reporting often are poor, further impairing reliability. Alarming studies from industry show miserable reproducibility of landmark studies. This paper discusses factors contributing to the lack of reproducibility and relevance of pre-clinical research. The conclusion: Publish less but of better quality and do not rely on the face value of animal studies.
登录
查看更多内容
影响因子:
2.7
作者:
Ersson, Clara;Moller, Peter;Moller, Lennart
通讯作者:
Moller, Lennart
影响因子:
4.4
作者:
Bebarta, V;Luyten, D;Heard, K
通讯作者:
Heard, K
DOI:
10.1073/pnas.1212247109
发表时间:
2012-10-16
影响因子:
11.1
作者:
Fang, Ferric C.;Steen, R. Grant;Casadevall, Arturo
通讯作者:
Casadevall, Arturo
影响因子:
3.7
作者:
Briel M;Müller KF;Meerpohl JJ;von Elm E;Lang B;Motschall E;Gloy V;Lamontagne F;Schwarzer G;Bassler D;OPEN Consortium
通讯作者:
OPEN Consortium
影响因子:
2.7
作者:
Coecke, S;Balls, M;Stokes, W
通讯作者:
Stokes, W